Derivatization with fatty acids in peptide and protein drug discovery
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Derivatization with fatty acids in peptide and protein drug discovery
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-24
DOI
10.1038/s41573-022-00529-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: An investigation on lipidated GLP-1 analogs
- (2022) Mariana Gallo et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
- (2022) Kirk M. Brown et al. NATURE BIOTECHNOLOGY
- Therapeutic RNA-silencing oligonucleotides in metabolic diseases
- (2022) Algera Goga et al. NATURE REVIEWS DRUG DISCOVERY
- Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect
- (2022) Flora Alexopoulou et al. Scientific Reports
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Opportunities and Challenges of Fatty Acid Conjugated Therapeutics
- (2021) Medha Bhat et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Trends in peptide drug discovery
- (2021) Markus Muttenthaler et al. NATURE REVIEWS DRUG DISCOVERY
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Importance of the route of insulin delivery to its control of glucose metabolism
- (2021) Dale S. Edgerton et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects
- (2021) Andreas B. Jordy et al. CLINICAL PHARMACOKINETICS
- Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
- (2021) Rune V. Overgaard et al. CLINICAL PHARMACOKINETICS
- Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis
- (2021) James F. Howard et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans
- (2021) Thomas B. Kjeldsen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
- (2021) Lone B Enebo et al. LANCET
- The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
- (2021) Alessandra Spada et al. MOLECULAR PHARMACEUTICS
- Development of Cagrilintide, a Long-Acting Amylin Analogue
- (2021) Thomas Kruse et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rational Development of Stable PYY3–36 Peptide Y2 Receptor Agonists
- (2021) Christian Poulsen et al. PHARMACEUTICAL RESEARCH
- Commemorating insulin's centennial: engineering insulin pharmacology towards physiology
- (2021) Peter Kurtzhals et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation
- (2021) Juris J. Meier Frontiers in Endocrinology
- Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing
- (2021) Erica Nishimura et al. BMJ Open Diabetes Research & Care
- Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist
- (2021) Martin Bossart et al. Cell Metabolism
- Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review
- (2021) Marc Evans et al. DIABETES OBESITY & METABOLISM
- Structure identification of circulating metabolites from somapacitan, a long-acting growth hormone derivative, and pharmacokinetics after single and multiple subcutaneous dosing in rats
- (2021) Hans Helleberg et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
- (2021) David C W Lau et al. LANCET
- Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
- (2021) Stefano Del Prato et al. LANCET
- Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays
- (2021) Axel Ducret et al. mAbs
- Anti-obesity drug discovery: advances and challenges
- (2021) Timo D. Müller et al. NATURE REVIEWS DRUG DISCOVERY
- The effect of fatty diacid acylation of human PYY3-36 on Y2 receptor potency and half-life in minipigs
- (2021) Søren Østergaard et al. Scientific Reports
- Fatty acylation enhances the cellular internalization and cytosolic distribution of a cystine-knot peptide
- (2021) Xinxin Gao et al. iScience
- Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial
- (2020) Gudmundur Johannsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of Binding Sites on Human Serum Albumin for Somapacitan, a Long-Acting Growth Hormone Derivative
- (2020) Eva Johansson et al. BIOCHEMISTRY
- Albumin-based drug designs for pharmacokinetic modulation
- (2020) Diego Pilati et al. Expert Opinion on Drug Metabolism & Toxicology
- Influence of Production Process and Scale on Quality of Polypeptide Drugs: a Case Study on GLP-1 Analogs
- (2020) Arne Staby et al. PHARMACEUTICAL RESEARCH
- Molecular engineering of safe and efficacious oral basal insulin
- (2020) Frantisek Hubálek et al. Nature Communications
- An intact C-terminal end of albumin is required for its long half-life in humans
- (2020) Jeannette Nilsen et al. Communications Biology
- Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation
- (2020) Neil Tanday et al. DIABETES OBESITY & METABOLISM
- Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity
- (2020) Sam Lear et al. JOURNAL OF MEDICINAL CHEMISTRY
- Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
- (2020) Julio Rosenstock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320
- (2020) Thomas B. Kjeldsen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles
- (2020) Annabelle Biscans et al. MOLECULAR THERAPY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-Activity Relationships and Characterization of Highly Selective, Long Acting, Peptide-based Cholecystokinin 1 Receptor (CCK-1R) Agonists
- (2019) Ulrich Sensfuss et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
- (2019) Inge B Halberg et al. Lancet Diabetes & Endocrinology
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- Development of long-acting recombinant glycoprotein hormones by increasing the carbohydrate content
- (2019) Fuad Fares et al. DRUG DISCOVERY TODAY
- Apelin peptides linked to anti‐serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivo
- (2019) Cai Read et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects
- (2019) Inge B. Halberg et al. CLINICAL PHARMACOKINETICS
- Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogs
- (2019) Justin M. Gregory et al. DIABETES OBESITY & METABOLISM
- Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs
- (2019) Berit Ø. Christoffersen et al. INTERNATIONAL JOURNAL OF OBESITY
- Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
- (2019) Richard Pratley et al. LANCET
- Half-Life Extending Modifications of Peptide YY3–36 Direct Receptor-Mediated Internalization
- (2019) Esben M. Bech et al. MOLECULAR PHARMACEUTICS
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
- (2019) Thazha P Prakash et al. NUCLEIC ACIDS RESEARCH
- Design of a Long-Acting and Selective MEG-Fatty Acid Stapled Prolactin-Releasing Peptide Analog
- (2019) Elsa Pflimlin et al. ACS Medicinal Chemistry Letters
- Chemical Methods for Selective Labeling of Proteins
- (2019) Dattatraya G. Rawale et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Disulfide‐Based Self‐Immolative Linkers and Functional Bioconjugates for Biological Applications
- (2019) Zhengyu Deng et al. MACROMOLECULAR RAPID COMMUNICATIONS
- Solid-Phase Thiol-ene Lipidation of Peptides for the Synthesis of a Potent CGRP Receptor Antagonist
- (2018) Margaret Anne Brimble et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Effect of Lipidation on the Self-Assembly of the Gut-Derived Peptide Hormone PYY3–36
- (2018) Jessica A. Hutchinson et al. BIOCONJUGATE CHEMISTRY
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
- (2018) Charlotte Granhall et al. CLINICAL PHARMACOKINETICS
- MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
- (2018) Philip Ambery et al. LANCET
- The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptides
- (2018) Heidi S. Schultz et al. PLoS One
- Evaluating and Mitigating the Immunogenicity of Therapeutic Proteins
- (2018) Zuben E. Sauna et al. TRENDS IN BIOTECHNOLOGY
- Improving siRNA Delivery In Vivo Through Lipid Conjugation
- (2018) Maire F. Osborn et al. Nucleic Acid Therapeutics
- Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide
- (2018) Marija Kuna et al. Scientific Reports
- Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability
- (2018) A. K. J. Gradel et al. Journal of Diabetes Research
- Harnessing albumin as a carrier for cancer therapies
- (2018) Ella N. Hoogenboezem et al. ADVANCED DRUG DELIVERY REVIEWS
- Long-Acting Human Growth Hormone Analogue by Noncovalent Albumin Binding
- (2018) Henrik S. Ramírez-Andersen et al. BIOCONJUGATE CHEMISTRY
- A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials
- (2018) Joachim Tillner et al. DIABETES OBESITY & METABOLISM
- Selective N-terminal acylation of peptides and proteins with a Gly-His tag sequence
- (2018) Manuel C. Martos-Maldonado et al. Nature Communications
- Design and Synthesis of Potent, Long-Acting Lipidated Relaxin-2 Analogs
- (2018) Avinash Muppidi et al. BIOCONJUGATE CHEMISTRY
- Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer
- (2018) Himgauri Naik et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
- (2018) Charlotte Granhall et al. CLINICAL PHARMACOKINETICS
- Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
- (2018) Stephen T. Buckley et al. Science Translational Medicine
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species
- (2017) Lene Jensen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes
- (2017) Melanie Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues
- (2017) Esben M. Bech et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Current State of Peptide Drug Discovery: Back to the Future?
- (2017) Antoine Henninot et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lipid–Drug Conjugate for Enhancing Drug Delivery
- (2017) Danielle Irby et al. MOLECULAR PHARMACEUTICS
- Targeting the N terminus for site-selective protein modification
- (2017) Christian B Rosen et al. Nature Chemical Biology
- Half-life extension using serum albumin-binding DARPin® domains
- (2017) Daniel Steiner et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools
- (2017) Kasper Lamberth et al. Science Translational Medicine
- Late-stage lipidation of fully elaborated tryptophan-containing peptides for improved pharmacokinetics
- (2017) Chunhui Huang et al. TETRAHEDRON LETTERS
- Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides
- (2017) Alessandro Zorzi et al. Nature Communications
- Factors affecting the physical stability (aggregation) of peptide therapeutics
- (2017) Karolina L. Zapadka et al. Interface Focus
- Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
- (2017) Christopher Sorli et al. Lancet Diabetes & Endocrinology
- Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
- (2017) Vanita R Aroda et al. Lancet Diabetes & Endocrinology
- The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency
- (2017) Kennett Sprogøe et al. Endocrine Connections
- Development of potent and long-acting HIV-1 fusion inhibitors
- (2016) Huihui Chong et al. AIDS
- Synthesis of Lipidated Proteins
- (2016) Tom Mejuch et al. BIOCONJUGATE CHEMISTRY
- Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier
- (2016) Jie Zhou et al. Chemical Biology & Drug Design
- Development of Potent and Metabolically Stable APJ Ligands with High Therapeutic Potential
- (2016) Cathleen Juhl et al. ChemMedChem
- Insulin degludec does not increase antibody formation versus insulin glargine: an evaluation of phase IIIa trials
- (2016) J. Vora et al. DIABETES OBESITY & METABOLISM
- Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates
- (2016) S. J. Henderson et al. DIABETES OBESITY & METABOLISM
- Half-life extended biotherapeutics
- (2016) Roland E. Kontermann EXPERT OPINION ON BIOLOGICAL THERAPY
- The molecular basis for the prolonged blood circulation of lipidated incretin peptides: Peptide oligomerization or binding to serum albumin?
- (2016) Ying Wang et al. JOURNAL OF CONTROLLED RELEASE
- Extension of in vivo half-life of biologically active molecules by XTEN protein polymers
- (2016) Vladimir N. Podust et al. JOURNAL OF CONTROLLED RELEASE
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Neoglycolipids for Prolonging the Effects of Peptides: Self-Assembling Glucagon-like Peptide 1 Analogues with Albumin Binding Properties and Potent in Vivo Efficacy
- (2016) Søren B. van Witteloostuijn et al. MOLECULAR PHARMACEUTICS
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery
- (2016) Peng-Yu Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acyl lipidation of a peptide: effects on activity and epidermal permeability in vitro
- (2016) Rima Caccetta et al. Drug Design Development and Therapy
- Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp
- (2015) Tiffany D. Farmer et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Self-Immolative Spacers: Kinetic Aspects, Structure-Property Relationships, and Applications
- (2015) Ahmed Alouane et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
- (2015) William R. Strohl BIODRUGS
- Peptide stapling techniques based on different macrocyclisation chemistries
- (2015) Yu Heng Lau et al. CHEMICAL SOCIETY REVIEWS
- Synthetic protein lipidation
- (2015) Rami N Hannoush CURRENT OPINION IN CHEMICAL BIOLOGY
- Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement
- (2015) Sofie Trier et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration
- (2015) L Maletínská et al. INTERNATIONAL JOURNAL OF OBESITY
- Design, Synthesis, and Characterization of Fatty Acid Derivatives of a Dimeric Peptide-Based Postsynaptic Density-95 (PSD-95) Inhibitor
- (2015) Klaus B. Nissen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
- (2015) Jesper Lau et al. JOURNAL OF MEDICINAL CHEMISTRY
- Transformation of Oligomers of Lipidated Peptide Induced by Change in pH
- (2015) Ying Wang et al. MOLECULAR PHARMACEUTICS
- Site-selective protein-modification chemistry for basic biology and drug development
- (2015) Nikolaus Krall et al. Nature Chemistry
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fc fusion as a platform technology: potential for modulating immunogenicity
- (2015) Ditza Levin et al. TRENDS IN BIOTECHNOLOGY
- Position and Length of Fatty Acids Strongly Affect Receptor Selectivity Pattern of Human Pancreatic Polypeptide Analogues
- (2014) Veronika Mäde et al. ChemMedChem
- A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance
- (2014) Hanne Haahr et al. CLINICAL PHARMACOKINETICS
- GSK2374697, a Novel Albumin-Binding Domain Antibody (AlbudAb), Extends Systemic Exposure of Exendin-4: First Study in Humans—PK/PD and Safety
- (2014) R L O’Connor-Semmes et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding
- (2014) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Reversible Albumin-Binding Growth Hormone Derivative is Well Tolerated and Possesses a Potential Once-Weekly Treatment Profile
- (2014) Michael Højby Rasmussen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake
- (2014) Louise S. Dalbøge et al. JOURNAL OF PEPTIDE SCIENCE
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- The immune epitope database (IEDB) 3.0
- (2014) Randi Vita et al. NUCLEIC ACIDS RESEARCH
- Acylation of Glucagon-Like Peptide-2: Interaction with Lipid Membranes and In Vitro Intestinal Permeability
- (2014) Sofie Trier et al. PLoS One
- Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
- (2014) R. Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Albumin as a versatile platform for drug half-life extension
- (2013) Darrell Sleep et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Preparation and Characterization of Albumin Conjugates of a Truncated Peptide YY Analogue for Half-Life Extension
- (2013) George K. Ehrlich et al. BIOCONJUGATE CHEMISTRY
- The insulin receptor changes conformation in unforeseen ways on ligand binding: Sharpening the picture of insulin receptor activation
- (2013) Colin W. Ward et al. BIOESSAYS
- Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat
- (2013) Weike Bao et al. Cardiovascular Diabetology
- Insulin Degludec: Pharmacokinetics in Patients with Renal Impairment
- (2013) István Kiss et al. CLINICAL PHARMACOKINETICS
- Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting α-MSH analog in healthy overweight and obese subjects
- (2013) Jane E. Royalty et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Site-specific fatty acid-conjugation to prolong protein half-life in vivo
- (2013) Sung In Lim et al. JOURNAL OF CONTROLLED RELEASE
- How insulin engages its primary binding site on the insulin receptor
- (2013) John G. Menting et al. NATURE
- PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
- (2013) M. Schlapschy et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer
- (2013) V. N. Podust et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Peptide lipidation stabilizes structure to enhance biological function
- (2013) Brian P. Ward et al. Molecular Metabolism
- Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
- (2012) Wolfgang F. Richter et al. AAPS Journal
- Ligand-Controlled Assembly of Hexamers, Dihexamers, and Linear Multihexamer Structures by the Engineered Acylated Insulin Degludec
- (2012) Dorte B. Steensgaard et al. BIOCHEMISTRY
- Preparation and evaluation of palmitic acid-conjugated exendin-4 with delayed absorption and prolonged circulation for longer hypoglycemia
- (2012) Juho Lee et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Identification and in Vivo and in Vitro Characterization of Long Acting and Melanocortin 4 Receptor (MC4-R) Selective α-Melanocyte-Stimulating Hormone (α-MSH) Analogues
- (2012) Kilian Conde-Frieboes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Alan J Garber et al. LANCET
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Simon Heller et al. LANCET
- RNA therapeutics: beyond RNA interference and antisense oligonucleotides
- (2012) Ryszard Kole et al. NATURE REVIEWS DRUG DISCOVERY
- Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
- (2012) Ib Jonassen et al. PHARMACEUTICAL RESEARCH
- Predictable and tunable half-life extension of therapeutic agents by controlled chemical release from macromolecular conjugates
- (2012) D. V. Santi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
- (2011) Paola Milla et al. CURRENT DRUG METABOLISM
- Pramlintide and the treatment of diabetes: a review of the data since its introduction
- (2011) Lisa M Younk et al. EXPERT OPINION ON PHARMACOTHERAPY
- Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Trials
- (2011) John B. Buse et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Acting Lipidated Analogue of Human Pancreatic Polypeptide Is Slowly Released into Circulation
- (2011) Kathrin Bellmann-Sickert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
- (2011) J. R. Cantor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycosylation of Therapeutic Proteins
- (2010) Ricardo J. Solá et al. BIODRUGS
- PEGylation of therapeutic proteins
- (2010) Simona JevsÌevar et al. Biotechnology Journal
- Patient perspectives on once-weekly medications for diabetes
- (2010) W. H. Polonsky et al. DIABETES OBESITY & METABOLISM
- Metabolism and Excretion of the Once-Daily Human Glucagon-Like Peptide-1 Analog Liraglutide in Healthy Male Subjects and Its In Vitro Degradation by Dipeptidyl Peptidase IV and Neutral Endopeptidase
- (2010) M. Malm-Erjefalt et al. DRUG METABOLISM AND DISPOSITION
- Effects of albumin-conjugated PYY on food intake: the respective roles of the circumventricular organs and vagus nerve
- (2010) Elena-Dana Baraboi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Population Pharmacokinetic Model of Human Insulin Following Different Routes of Administration
- (2010) Elizabeth Potocka et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics
- (2010) Su Young Chae et al. JOURNAL OF CONTROLLED RELEASE
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon
- (2010) A. Walker et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- A Portable Albumin Binder from a DNA-Encoded Chemical Library
- (2008) Christoph E. Dumelin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial
- (2008) P. C. Bartley et al. DIABETIC MEDICINE
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
- (2008) Alan Garber et al. LANCET
- Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
- (2008) L. J. Holt et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Engineering of a femtomolar affinity binding protein to human serum albumin
- (2008) A. Jonsson et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan
- (2008) Morten Nielsen et al. PLoS Computational Biology
- Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin
- (2002) Martin Linhult et al. PROTEIN SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started